Neuraxis grants RSUs to CEO, CFO and officers, plus 127,120 shares to directors
Neuraxis disclosed equity compensation actions taken in July and August 2026. A stock option exchange approved by stockholders on June 10, 2026 took effect July 24, swapping 1,319,394 options for an equal number of restricted stock units, and on August 13 the company granted new RSUs to four executives and one-time share awards to independent directors. The filing says the director awards address compensation that was below market levels, which adds to shareholder dilution.
Key points
- Stock option exchange of 1,319,394 options into RSUs took effect July 24, 2026, vesting immediately for executives Brian Carrico, Adrian Miranda and Thomas Carrico.
- On August 13, 2026, the company granted RSUs to Brian Carrico (193,329), Timothy Henrichs (141,479), Adrian Miranda (133,341) and Thomas Carrico (135,906), vesting in three equal annual installments.
- On August 13, 2026, independent directors received a total of 127,120 shares of common stock as one-time awards for prior board service.
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 19, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.